These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 8622306)

  • 1. Cardiopulmonary Bypass-Induced Inflammation and Myocardial Ischemia and Reperfusion Injury Stimulates Accumulation of Soluble MER.
    Becker AC; Lantz CW; Forbess JM; Epting CL; Thorp EB
    Pediatr Crit Care Med; 2021 Sep; 22(9):822-831. PubMed ID: 33813548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of myocardial reperfusion injury by high-dose beta-blockade with esmolol.
    Geissler HJ
    Thorac Cardiovasc Surg; 2002 Dec; 50(6):367-72. PubMed ID: 12457318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esmolol and cardiopulmonary bypass during reperfusion reduce myocardial infarct size in dogs.
    Geissler HJ; Davis KL; Buja LM; Laine GA; Brennan ML; Mehlhorn U; Allen SJ
    Ann Thorac Surg; 2001 Dec; 72(6):1964-9. PubMed ID: 11789778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockade as an alternative to cardioplegic arrest during cardiopulmonary bypass.
    Warters RD; Allen SJ; Davis KL; Geissler HJ; Bischoff I; Mutschler E; Mehlhorn U
    Ann Thorac Surg; 1998 Apr; 65(4):961-6. PubMed ID: 9564910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of esmolol given during cardiopulmonary bypass.
    Cork RC; Kramer TH; Dreischmeier B; Behr S; DiNardo JA
    Anesth Analg; 1995 Jan; 80(1):28-40. PubMed ID: 7802296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia.
    Scorsin M; Mebazaa A; Al Attar N; Medini B; Callebert J; Raffoul R; Ramadan R; Maillet JM; Ruffenach A; Simoneau F; Nataf P; Payen D; Lessana A
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1022-9. PubMed ID: 12771874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model.
    Laub GW; Muralidharan S; Reibman J; Fernandez J; Anderson WA; Gu J; Daloisio C; McGrath LB; Mulligan LJ
    J Thorac Cardiovasc Surg; 1996 May; 111(5):1085-91. PubMed ID: 8622306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
    Kloner RA; Kirshenbaum J; Lange R; Antman EM; Braunwald E
    Am J Cardiol; 1985 Oct; 56(11):40F-48F. PubMed ID: 2864848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative use of esmolol.
    Reves JG; Flezzani P
    Am J Cardiol; 1985 Oct; 56(11):57F-62F. PubMed ID: 2864850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupont critical care lecture: role of ultrashort-acting beta-blockers in the perioperative period.
    Kaplan JA
    J Cardiothorac Anesth; 1988 Oct; 2(5):683-91. PubMed ID: 17171962
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.